REFRESH RELIEVA PF XTRA- carboxymethylcellulose sodium and glycerin solution/ drops 
Allergan, Inc.

----------

REFRESH RELIEVA PF Xtra
Drug Facts

Active ingredients

Carboxymethylcellulose sodium 0.5%
Glycerin 0.9%

Purpose

Eye lubricant
Eye lubricant

Uses

Warnings

Stop use and ask a doctor if

you experience eye pain, changes in vision, continued redness or irritation of the eye, or if the condition worsens or persists for more than 72 hours.

Keep out of reach of children.

If swallowed, get medical help or contact a Poison Control Center right away.

Directions

Other information

Inactive ingredients

Boric acid; calcium chloride dihydrate; erythritol; levocarnitine; magnesium chloride hexahydrate; potassium chloride; purified water; sodium borate decahydrate; sodium citrate dihydrate; sodium hyaluronate; and trehalose. May contain hydrochloric acid and/or sodium hydroxide to adjust pH.

Questions or comments?

1.800.678.1605

refresheyedrops.com

PRINCIPAL DISPLAY PANEL

NDC 0023-3782-10

New
PRESERVATIVE-FREE
Refresh®
RELIEVA® PF
Xtra
Lubricant Eye Drops
With
HydroCell®
Fast-Acting Relief
Hydrates & Protects
Dry, Sensitive Eyes
0.33 fl oz (10 mL) Sterile

PRINCIPAL DISPLAY PANEL
NDC 0023-3782-10
New
PRESERVATIVE-FREE
Refresh®
RELIEVA® PF
Xtra
Lubricant Eye Drops
With
HydroCell®
Fast-Acting Relief
Hydrates & Protects
Dry, Sensitive Eyes
0.33 fl oz (10 mL) Sterile

REFRESH RELIEVA PF XTRA 
carboxymethylcellulose sodium and glycerin solution/ drops
Product Information
Product TypeHUMAN OTC DRUGItem Code (Source)NDC:0023-3782
Route of AdministrationOPHTHALMIC
Active Ingredient/Active Moiety
Ingredient NameBasis of StrengthStrength
CARBOXYMETHYLCELLULOSE SODIUM (UNII: K679OBS311) (CARBOXYMETHYLCELLULOSE - UNII:05JZI7B19X) CARBOXYMETHYLCELLULOSE SODIUM5 mg  in 1 mL
GLYCERIN (UNII: PDC6A3C0OX) (GLYCERIN - UNII:PDC6A3C0OX) GLYCERIN9 mg  in 1 mL
Inactive Ingredients
Ingredient NameStrength
BORIC ACID (UNII: R57ZHV85D4)  
CALCIUM CHLORIDE (UNII: M4I0D6VV5M)  
ERYTHRITOL (UNII: RA96B954X6)  
LEVOCARNITINE (UNII: 0G389FZZ9M)  
MAGNESIUM CHLORIDE (UNII: 02F3473H9O)  
POTASSIUM CHLORIDE (UNII: 660YQ98I10)  
WATER (UNII: 059QF0KO0R)  
SODIUM BORATE (UNII: 91MBZ8H3QO)  
TRISODIUM CITRATE DIHYDRATE (UNII: B22547B95K)  
HYALURONATE SODIUM (UNII: YSE9PPT4TH)  
TREHALOSE (UNII: B8WCK70T7I)  
HYDROCHLORIC ACID (UNII: QTT17582CB)  
SODIUM HYDROXIDE (UNII: 55X04QC32I)  
Packaging
#Item CodePackage DescriptionMarketing Start DateMarketing End Date
1NDC:0023-3782-101 in 1 CARTON03/01/2024
110 mL in 1 BOTTLE, DROPPER; Type 0: Not a Combination Product
2NDC:0023-3782-351 in 1 CARTON03/01/2024
210 mL in 1 BOTTLE, DROPPER; Type 0: Not a Combination Product
3NDC:0023-3782-501 in 1 CARTON03/01/2024
33.5 mL in 1 BOTTLE, DROPPER; Type 0: Not a Combination Product
Marketing Information
Marketing CategoryApplication Number or Monograph CitationMarketing Start DateMarketing End Date
OTC Monograph DrugM01803/01/2024
Labeler - Allergan, Inc. (144796497)

Revised: 3/2024
Document Id: 50112925-df71-4479-8b99-f91010b7e65c
Set id: b51b8a75-8faa-430f-8f7e-ee58d3d13f2e
Version: 1
Effective Time: 20240301
 
Allergan, Inc.